Your browser doesn't support javascript.
loading
Zijin powder in inhibiting H22 mice solid and ascites liver cancer: experimental study / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 1346-1348, 2005.
Article in Chinese | WPRIM | ID: wpr-239681
ABSTRACT
<p><b>OBJECTIVE</b>To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.</p><p><b>METHOD</b>The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.</p><p><b>RESULT</b>The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.</p><p><b>CONCLUSION</b>Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Pharmacology / Powders / Drugs, Chinese Herbal / Random Allocation / Therapeutic Uses / Dose-Response Relationship, Drug / Drug Therapy / Liver Neoplasms / Phytotherapy / Antineoplastic Agents, Phytogenic Type of study: Controlled clinical trial Limits: Animals / Female / Humans / Male Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2005 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pharmacology / Powders / Drugs, Chinese Herbal / Random Allocation / Therapeutic Uses / Dose-Response Relationship, Drug / Drug Therapy / Liver Neoplasms / Phytotherapy / Antineoplastic Agents, Phytogenic Type of study: Controlled clinical trial Limits: Animals / Female / Humans / Male Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2005 Type: Article